Intellectual Property - April 29, 2019
Elekta files patent infringement lawsuit
The company has filed a patent infringement lawsuit against ZAP Surgical Systems Inc in the United States District Court for the Northern District of California. The lawsuit was filed by Elekta Limited and Elekta Inc. and asserts that the manufacture, importation, advertising, sale, and use of the ZAP-X® Gyroscopic Radiosurgery™ Platform infringes U.S. Patent No. […]
MedTech Business - April 9, 2019
Elekta invests in iRT Systems
The company has purchased a minority stake in the German company iRT Systems, in order to improve its quality assurance (QA) offering to clinics and hospitals. For the past six years, iRT Systems has developed the Integral Quality Monitor (IQM) system in cooperation with Princess Margaret Cancer Centre, part of the University Health Network (UHN), […]
MedTech Award - March 27, 2019
Elekta receives Red Dot Award
Elekta and DCA Design International are the winners of the Red Dot Award: Product Design 2019, one of the world’s largest design competitions. Elekta Unity is the only high-field magnetic resonance radiation therapy system that enables clinicians to see what they treat while the treatment is taking place. “We are honored to have received this […]
MedTech Business - March 25, 2019
Elekta receives Medical Device License from Health Canada
The company’s Elekta Unity magnetic resonance radiation therapy (MR/RT) system has received a Medical Device License from Health Canada, clearing the technology for commercial sales in Canada. “We are pleased to have achieved this important milestone toward making Elekta Unity available in Canada and expect that this important new treatment option will become available to […]
MedTech article - June 19, 2017
New data from Elekta’s lung research group
Elekta has announced new data demonstrating stereotactic body radiation therapy (SBRT) is a safe treatment option for early-stage lung cancer patients aged 80 or older. The results, which were based on data from more than 1,000 patients across five institutions that comprise the Elekta Lung Research Group, are available online and will be published in […]
In a new job - April 15, 2017
Elekta appoints new Chief Financial Officer
Gustaf Salford has been appointed Executive Vice President and Chief Financial Officer at Elekta, effective July 1, 2017. Salford will be succeeding Håkan Bergström, who will retire per the same date. Salford joined Elekta in 2009 and has worked in several financial leadership roles within the company, most recently as Head of Group Business Control. […]
